WallStreetZenWallStreetZen

NASDAQ: TKNO
Alpha Teknova Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TKNO stock forecasts and price targets.

Forecast return on equity

Is TKNO forecast to generate an efficient return?

Company
N/A
Industry
31.45%
Market
204.34%

Forecast return on assets

Is TKNO forecast to generate an efficient return on assets?

Company
N/A
Industry
13.7%

TKNO earnings per share forecast

What is TKNO's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.36

TKNO revenue forecast

What is TKNO's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$40.4M+7.03%
Avg 2 year Forecast
$44.3M+17.37%
TKNO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TKNO revenue growth forecast

How is TKNO forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
7.03%
Industry
5.27%
Market
55.84%
TKNO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TKNO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TKNO vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TKNO$5.40N/AN/A
EBS$5.17$13.50+161.12%Strong Buy
AQST$3.12$11.40+265.38%Strong Buy
ESPR$1.63$7.00+329.45%Buy
LFCR$6.60$8.00+21.21%Buy
View Top Pharmaceutical Stocks

Alpha Teknova Stock Forecast FAQ

What is TKNO's earnings growth forecast for 2025-2025?

(NASDAQ: TKNO) Alpha Teknova's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 73.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 67.6%.

Alpha Teknova's earnings in 2025 is -$26,745,000.

In 2025, TKNO is forecast to generate -$19,237,250 in earnings, with the lowest earnings forecast at -$19,237,250 and the highest earnings forecast at -$19,237,250.

If you're new to stock investing, here's how to buy Alpha Teknova stock.

What is TKNO's revenue growth forecast for 2025-2026?

(NASDAQ: TKNO) Alpha Teknova's forecast annual revenue growth rate of 7.03% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 5.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.84%.

Alpha Teknova's revenue in 2025 is $37,745,000.On average, 1 Wall Street analysts forecast TKNO's revenue for 2025 to be $2,158,846,962, with the lowest TKNO revenue forecast at $2,158,846,962, and the highest TKNO revenue forecast at $2,158,846,962.

In 2026, TKNO is forecast to generate $2,367,250,506 in revenue, with the lowest revenue forecast at $2,367,250,506 and the highest revenue forecast at $2,367,250,506.

What is TKNO's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: TKNO) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.7%.

What is TKNO's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: TKNO) Alpha Teknova's current Earnings Per Share (EPS) is -$0.57. In 2025, TKNO's EPS is forecast to hit -$0.36 (min: -$0.36, max: -$0.36).

What is TKNO's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: TKNO) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.